|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Savagner P: The epithelial-mesenchymal
transition (EMT) phenomenon. Ann Oncol. 21(Suppl 7): vii89–vii92.
2010.PubMed/NCBI
|
|
3
|
Le Bras GF, Taubenslag KJ and Andl CD: The
regulation of cell-cell adhesion during epithelial-mesenchymal
transition, motility and tumor progression. Cell Adh Migr.
6:365–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Wever O, Pauwels P, De Craene B, Sabbah
M, Emami S, Redeuilh G, Gespach C, Bracke M and Berx P: Molecular
and pathological signatures of epithelial-mesenchymal transitions
at the cancer invasion front. Histochem Cell Biol. 130:481–494.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ansieau S, Bastid J, Doreau A, Morel AP,
Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S,
et al: Induction of EMT by twist proteins as a collateral effect of
tumor-promoting inactivation of premature senescence. Cancer Cell.
14:79–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cavallaro U and Christofori G: Cell
adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pećina-Slaus N: Tumor suppressor gene
E-cadherin and its role in normal and malignant cells. Cancer Cell
Int. 3:172003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponnusamy MP, Lakshmanan I, Jain M, Das S,
Chakraborty S, Dey P and Batra SK: MUC4 mucin-induced epithelial to
mesenchymal transition: A novel mechanism for metastasis of human
ovarian cancer cells. Oncogene. 29:5741–5754. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurrey NK, K A and Bapat SA: Snail and
Slug are major determinants of ovarian cancer invasiveness at the
transcription level. Gynecol Oncol. 97:155–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmed N, Thompson EW and Quinn MA:
Epithelial mesenchymal interconversions in normal ovarian surface
epithelium and ovarian carcinomas: an exception to the norm. J Cell
Physiol. 213:581–588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davidson B, Tropé CG and Reich R:
Epithelial-mesenchymal transition in ovarian carcinoma. Front
Oncol. 2:332012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scully RE: Pathology of ovarian cancer
precursors. J Cell Biochem Suppl. 23:208–218. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okamoto S, Okamoto A, Nikaido T, Saito M,
Takao M, Yanaihara N, Takakura S, Ochiai K and Tanaka T:
Mesenchymal to epithelial transition in the human ovarian surface
epithelium focusing on inclusion cysts. Oncol Rep. 21:1209–1214.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lili LN, Matyunina LV, Walker LD, Wells
SL, Benigno BB and McDonald JF: Molecular profiling supports the
role of epithelial-to-mesenchymal transition (EMT) in ovarian
cancer metastasis. J Ovarian Res. 6:492013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshida J, Horiuchi A, Kikuchi N, Hayashi
A, Osada R, Ohira S, Shiozawa T and Konishi I: Changes in the
expression of E-cadherin repressors, Snail, Slug, SIP1 and Twist,
in the development and progression of ovarian carcinoma: the
important role of Snail in ovarian tumorigenesis and progression.
Med Mol Morphol. 42:82–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hosono S, Kajiyama H, Terauchi M, Shibata
K, Ino K, Nawa A and Kikkawa F: Expression of Twist increases the
risk for recurrence and for poor survival in epithelial ovarian
carcinoma patients. Br J Cancer. 96:314–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tuhkanen H, Soini Y, Kosma VM, Anttila M,
Sironen R, Hämäläinen K, Kukkonen L, Virtanen I and Mannermaa A:
Nuclear expression of Snail1 in borderline and malignant epithelial
ovarian tumours is associated with tumour progression. BMC Cancer.
9:2892009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maines-Bandiera SL and Auersperg N:
Increased E-cadherin expression in ovarian surface epithelium: an
early step in metaplasia and dysplasia? Int J Gynecol Pathol.
16:250–255. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davidson B, Berner A, Nesland JM, Risberg
B, Berner HS, Tropè CG, Kristensen GB, Bryne M and Florenes Ann V:
E-cadherin and alpha-, beta- and gamma-catenin protein expression
is up-regulated in ovarian carcinoma cells in serous effusions. J
Pathol. 192:460–469. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sundfeldt K: Cell-cell adhesion in the
normal ovary and ovarian tumors of epithelial origin; an exception
to the rule. Mol Cell Endocrinol. 202:89–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davidson B: Ovarian carcinoma and serous
effusions. Changing views regarding tumor progression and review of
current literature. Anal Cell Pathol. 23:107–128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voutilainen KA, Anttila MA, Sillanpää SM,
Ropponen KM, Saarikoski SV, Juhola MT and Kosma VM: Prognostic
significance of E-cadherin-catenin complex in epithelial ovarian
cancer. J Clin Pathol. 59:460–467. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rodriguez FJ, Lewis-Tuffin LJ and
Anastasiadis PZ: E-cadherin's dark side: possible role in tumor
progression. Biochim Biophys Acta. 1826:23–31. 2012.PubMed/NCBI
|
|
25
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du W, Liu X, Fan G, Zhao X, Sun Y, Wang T,
Zhao R, Wang G, Zhao C, Zhu Y, et al: From cell membrane to the
nucleus: an emerging role of E-cadherin in gene transcriptional
regulation. J Cell Mol Med. 18:1712–1719. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elloul S, Silins I, Tropé CG, Benshushan
A, Davidson B and Reich R: Expression of E-cadherin transcriptional
regulators in ovarian carcinoma. Virchows Arch. 449:520–528. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vernon AE and LaBonne C: Tumor metastasis:
a new twist on epithelial-mesenchymal transitions. Curr Biol.
14:R719–R721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Elloul S, Vaksman O, Stavnes HT, Trope CG,
Davidson B and Reich R: Mesenchymal-to-epithelial transition
determinants as characteristics of ovarian carcinoma effusions.
Clin Exp Metastasis. 27:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gamba CO, Campos LC, Negreiros-Lima GL,
Maciel-Lima K, Sousa LP, Estrela-Lima A, Ferreira E and Cassali GD:
ZEB2 and ZEB1 expression in a spontaneous canine model of invasive
micropapillary carcinoma of the mammary gland. Res Vet Sci.
97:554–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li YM, Xu SC, Li J, Han KQ, Pi HF, Zheng
L, Zuo GH, Huang XB, Li HY, Zhao HZ, et al: Epithelial-mesenchymal
transition markers expressed in circulating tumor cells in
hepatocellular carcinoma patients with different stages of disease.
Cell Death Dis. 4:e8312013. View Article : Google Scholar : PubMed/NCBI
|
